ID   OCGH_ATRT
AC   CVCL_A1GR
SY   AT/RT
DR   cancercelllines; CVCL_A1GR
DR   JCRB; JCRB1868
DR   Wikidata; Q102114678
RX   PubMed=32997328;
CC   Population: Japanese.
CC   Doubling time: 19.3 hours (PubMed=32997328).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg53Ter (c.157C>T); ClinVar=VCV000944246; Zygosity=Unspecified (PubMed=32997328).
CC   Misspelling: ATRT_OCGH; PubMed=32997328; Note=In abstract.
CC   Derived from site: In situ; Brain, pineal gland; UBERON=UBERON_0001905.
ST   Source(s): JCRB=JCRB1868; PubMed=32997328
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
RX   PubMed=32997328; DOI=10.1007/s13577-020-00438-3;
RA   Nakano, Yoshiko
RA   Takadera, Mutsumi
RA   Miyazaki, Makoto
RA   Qiao, Zhi-Wei
RA   Nakajima, Kosei
RA   Noguchi, Rei
RA   Oyama, Rieko
RA   Kimura, Yui
RA   Okuhiro, Yuki
RA   Yamasaki, Kai
RA   Kunihiro, Noritsugu
RA   Fukushima, Hiroko
RA   Inoue, Takeshi
RA   Hara, Junichi
RA   Ozawa, Tatsuya
RA   Kondo, Tadashi
RA   Ichimura, Koichi
RT   "Drug screening with a novel tumor-derived cell line identified
RT   alternative therapeutic options for patients with atypical
RT   teratoid/rhabdoid tumor.";
RL   Hum. Cell 34:271-278(2021).
//